Marchetti A.; Rosellini M.; Rizzo A.; Mollica V.; Battelli N.; Massari F.; Santoni M., An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 2323 - 2336 [articolo]
Santoni M.; Piva F.; Porta C.; Bracarda S.; Heng D.Y.; Matrana M.R.; Grande E.; Mollica V.; Aurilio G.; Rizzo M.; Giulietti M.; Montironi R.; Massari F., Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 84 - 92 [articolo]
De Giglio A.; Scorsetti M.; Franceschini D.; Massari F.; Ardizzoni A., Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach, «EUROPEAN JOURNAL OF CANCER», 2021, 143, pp. 75 - 77 [articolo]
Santoni M.; Massari F.; Bracarda S.; Procopio G.; Milella M.; De Giorgi U.; Basso U.; Aurilio G.; Incorvaia L.; Martignetti A.; Rizzo M.; Carteni G.; Grande E.; Matrana M.R.; Crabb S.J.; Vau N.; Sorgentoni G.; Cimadamore A.; Montironi R.; Battelli N., Body mass index in patients treated with cabozantinib for advanced renal cell carcinoma: A new prognostic factor?, «DIAGNOSTICS», 2021, 11, Article number: 138, pp. 1 - 10 [articolo]Open Access
Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucci C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F., Bone targeting agents in patients with metastatic prostate cancer: State of the art, «CANCERS», 2021, 13, Article number: 546, pp. 1 - 13 [articolo]Open Access
Mollica, Veronica; Franceschini, Tania; Gruppioni, Elisa; Rizzo, Alessandro; Ricci, Costantino; Schiavina, Riccardo; Brunocilla, Eugenio; Ardizzoni, Andrea; Fiorentino, Michelangelo; Giunchi, Francesca; Massari, Francesco, Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 219, Article number: 153350, pp. 1 - 7 [articolo]
Mollica, Veronica; Franceschini, Tania; Gruppioni, Elisa; Rizzo, Alessandro; Ricci, Costantino; Schiavina, Riccardo; Brunocilla, Eugenio; Ardizzoni, Andrea; Fiorentino, Michelangelo; Giunchi, Francesca; Massari, Francesco, Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 219, pp. 153350 - 153356 [articolo]
Santoni M.; Massari F.; Grande E.; Procopio G.; Matrana M.R.; Rizzo M.; De Giorgi U.; Basso U.; Milella M.; Iacovelli R.; Aurilio G.; Incorvaia L.; Buti S.; Caffo O.; Fornarini G.; Carrozza F.; Mollica V.; Rizzo A.; Farag F.; Molina-Cerrillo J.; Battelli N., Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study, «TARGETED ONCOLOGY», 2021, 16, pp. 625 - 632 [articolo]
Rizzo A.; Mollica V.; Santoni M.; Massari F., Cancer immunotherapy: Current and future perspectives on a therapeutic revolution, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 5246, pp. 1 - 3 [articolo]Open Access
Cimadamore A.; Cheng L.; Massari F.; Santoni M.; Pepi L.; Franzese C.; Scarpelli M.; Lopez-Beltran A.; Galosi A.B.; Montironi R., Circulating tumor dna testing for homology recombination repair genes in prostate cancer: From the lab to the clinic, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 5522, pp. 1 - 15 [articolo]Open Access
Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Montironi R.; Ardizzoni A.; Massari F., Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis, «IMMUNOTHERAPY», 2021, 13, pp. 783 - 793 [articolo]
Rizzo A.; Mollica V.; Massari F., Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer, «JAMA ONCOLOGY», 2021, 7, pp. 1068 - 1068 [articolo]
Rizzo A.; Rosellini M.; Marchetti A.; Mollica V.; Massari F., Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: A critical overview of recent evidence, «IMMUNOTHERAPY», 2021, 13, pp. 685 - 692 [articolo]
Maria Massucci; Veronica Mollica; Alessandro Rizzo; Laura Ventrella; Ilaria Maggio; Lisa Manuzzi; Lidia Gatto; Giovanni Brandi; Francesco Massari, Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report, «MEDICINES», 2021, 8, Article number: 5, pp. 1 - 4 [articolo]Open Access
Ciccarese F.; Piccinino A.; Brocchi S.; Balacchi C.; Dall'Olio F.G.; Massari F.; Rihawi K.; Paccapelo A.; Ardizzoni A.; Golfieri R., Expected and non-expected immune-related adverse events detectable by CT, «EUROPEAN JOURNAL OF RADIOLOGY», 2021, 138, Article number: 109617, pp. 1 - 7 [articolo]
